These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12186278)

  • 21. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
    Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
    Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of varicella vaccine.
    Takahashi M; Asano Y; Kamiya H; Baba K; Ozaki T; Otsuka T; Yamanishi K
    J Infect Dis; 2008 Mar; 197 Suppl 2():S41-4. PubMed ID: 18419406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenetic tropism of varicella-zoster virus to primary human hepatocytes and attenuating tropism of Oka varicella vaccine strain to neonatal dermal fibroblasts.
    Shiraki K; Yoshida Y; Asano Y; Yamanishi K; Takahashi M
    J Infect Dis; 2003 Dec; 188(12):1875-7. PubMed ID: 14673767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1.
    Armenian SH; Han JY; Dunaway TM; Church JA
    Pediatr Infect Dis J; 2006 Apr; 25(4):368-70. PubMed ID: 16567993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine.
    Gomi Y; Ozaki T; Nishimura N; Narita A; Suzuki M; Ahn J; Watanabe N; Koyama N; Ushida H; Yasuda N; Nakane K; Funahashi K; Fuke I; Takamizawa A; Ishikawa T; Yamanishi K; Takahashi M
    Vaccine; 2008 Oct; 26(44):5627-32. PubMed ID: 18706951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine Oka varicella-zoster virus genotypes are monomorphic in single vesicles and polymorphic in respiratory tract secretions.
    Quinlivan MA; Gershon AA; Nichols RA; La Russa P; Steinberg SP; Breuer J
    J Infect Dis; 2006 Apr; 193(7):927-30. PubMed ID: 16518753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine.
    Levin MJ; DeBiasi RL; Bostik V; Schmid DS
    J Infect Dis; 2008 Nov; 198(10):1444-7. PubMed ID: 18826373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of postexposure immunization with live attenuated varicella vaccine in the household setting--a pilot study.
    Mor M; Harel L; Kahan E; Amir J
    Vaccine; 2004 Dec; 23(3):325-8. PubMed ID: 15530676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus.
    Quinlivan ML; Gershon AA; Steinberg SP; Breuer J
    J Infect Dis; 2004 Aug; 190(4):793-6. PubMed ID: 15272408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular analysis of the Oka vaccine strain of varicella-zoster virus.
    Yamanishi K
    J Infect Dis; 2008 Mar; 197 Suppl 2():S45-8. PubMed ID: 18419407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccine Oka variants and sequence variability in vaccine-related skin lesions.
    Breuer J; Schmid DS
    J Infect Dis; 2008 Mar; 197 Suppl 2():S54-7. PubMed ID: 18419409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain.
    Sauerbrei A; Eichhorn U; Gawellek S; Egerer R; Schacke M; Wutzler P
    J Med Virol; 2003 Oct; 71(2):313-9. PubMed ID: 12938208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Herpes zoster due to Oka vaccine strain of varicella zoster virus in an immunosuppressed child post cord blood transplant.
    Chan Y; Smith D; Sadlon T; Scott JX; Goldwater PN
    J Paediatr Child Health; 2007 Oct; 43(10):713-5. PubMed ID: 17854459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus.
    Quinlivan M; Gershon AA; Steinberg SP; Breuer J
    J Med Virol; 2005 Jan; 75(1):174-80. PubMed ID: 15543576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful vaccination against varicella zoster virus prior to kidney transplantation.
    Geel A; Zuidema W; van Gelder T; van Doornum G; Weimar W
    Transplant Proc; 2005 Mar; 37(2):952-3. PubMed ID: 15848586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Varicella zoster virus: vaccination and implications in children with renal failure.
    Fadrowski JJ; Furth SL
    Expert Rev Vaccines; 2004 Jun; 3(3):291-8. PubMed ID: 15176945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of the varicella vaccine in immunocompromised individuals.
    Sartori AM
    Int J Infect Dis; 2004 Sep; 8(5):259-70. PubMed ID: 15325594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Varicella zoster virus serostatus before and after kidney transplantation, and vaccination of adult kidney transplant candidates.
    Geel AL; Landman TS; Kal JA; van Doomum GJ; Weimar W
    Transplant Proc; 2006 Dec; 38(10):3418-9. PubMed ID: 17175291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunization against varicella and zoster].
    Floret D
    Bull Acad Natl Med; 2007 Jun; 191(6):1051-64; discussion 1064-7. PubMed ID: 18402164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.